Serzone recall bristol myers

Common Questions and Answers about Serzone recall bristol myers

serzone

Avatar m tn A U.S. federal court has invalidated the U.S. patent on Bristol-Myers Squibb Co's Baraclude treatment for hepatitis B after a challenge from generic drugmaker Teva Pharmaceutical Industries Ltd, Bristol-Myers said on Tuesday. "We are disappointed with the court's decision and believe it is incorrect," Bristol-Myers spokeswoman Laura Hortas said. She said the company is considering whether to appeal the ruling by the U.S. District Court in Delaware.
Avatar n tn org/petitions/gilead-sciences-please-collaborate-with-bristol-myers-for-the-cure-for-hepatitis-c-now. Please sign this petition to release the two pill cure for hep c!
Avatar f tn , senior vice president, Global Development and Medical Affairs, Bristol-Myers Squibb. “Bristol-Myers Squibb remains committed to developing medicines for the treatment of diseases with serious unmet medical need, including diseases of the liver such as hepatitis C, hepatitis B, and liver cancer.
Avatar m tn http://www.businesswire.com/news/home/20120107005030/en/Bristol-Myers-Squibb-Acquire-Inhibitex Inhibitex is a clinical-stage biopharmaceutical company dedicated to the development of innovative products that can treat or prevent serious infections, whose primary focus is on the development of nucleotide/nucleoside analogs for the treatment of hepatitis C virus (HCV).
Avatar f tn court has struck Baraclude from the patent list. The Bristol-Myers Squibb ($BMY) hepatitis B drug saw its composition of matter patent invalidated in a court fight with Teva Pharmaceutical Industries ($TEVA), which wants to sell its own version. The patent had been due to expire in 2015. It's unclear whether the ruling will expose Baraclude to immediate generic competition.
Avatar m tn Good news In case you have not heard Bristol Myers is filing in japan for first oral treatment for genotype one . We are not in Japan but still good news as I think Gilead and Abbvie will push harder to release there products faster , big companies and money talks . Also this is good I think because if it was only Gilead in this race , the price of the there treatment would be extremely expensive as Gilead are well known to be very expensive .
163305 tn?1333668571 //www.change.
Avatar f tn included by Bristol-Myers for non-responders. Anybody out there who knows anything about this drug or anybody who is already involved in the study and can share. Thank You so much!
Avatar m tn More info about Phase III Daclatasvir and Sofosbuvir and why Bristol-Myers Squibb is the sponsor and not Gilead Bristol-Myers looks to rival Gilead for the key to conquering the hep C market January 14, 2014 | By John Carroll No matter how hard Bristol-Myers Squibb ($BMY) tried to shame Gilead into pursuing studies for a combination of its hep C drug daclatasvir and the newly approved Sovaldi (sofosbuvir), Gilead Sciences ($GILD) wouldn't budge.
Avatar m tn Bristol-Myers Squibb Co. (BMY) (BMY) lost ground in the race to develop a stand-alone hepatitis C pill after the company suspended testing of an experimental drug for the disease that cost it $2.5 billion to buy earlier this year. The shares fell as much as 5.9 percent in early trading today after Bristol said yesterday it wouldn’t continue to administer the compound, known as BMS-986094, after a patient developed heart failure, what the company called a “serious safety issue” in a statement.
Avatar f tn bad news on a Bristol Myers n all oral treatment...BMS-986094, Bristol-Myers Despite paying big money for BMS-986094, Bristol-Myers has suspended testing on this experimental medicine for Hepatitis C after one person developed heart failure and eight others were hospitalized. Bristol-Myers Drops Hepatitis C Drug After Patient Death Bloomberg News By Ryan Flinn on August 24, 2012 Bristol-Myers Squibb Co. (BMY) has abandoned an experimental hepatitis C pill it bought for $2.
Avatar m tn A new drug combination (Gilead Sciences 'GS-7977' + Bristol-Myers' 'Daclatasvir') has highest cure rate in genotype 1 patients and high rate in genotypes 2 & 3 without the utilization of Interferon or Ribavirin. But due to some minor setbacks, Gilead Sciences elected not to take these drugs into Phase III trials. Hence, this petition is requesting them to continue their research to Phase III.
215858 tn?1420171556 Bristol-Myers files NDAs to FDA for daclatasvir and asunaprevir to treat hepatitis C US-based biopharmaceutical firm Bristol-Myers Squibb (BMS) has submitted new drug applications (NDAs) to the US Food and Drug Administration (FDA) for the investigational products daclatasvir (DCV), an NS5A replication complex inhibitor, and asunaprevir (ASV), a NS3 protease inhibitor, indicated for the treatment of Hepatitis C.
Avatar m tn //www.change.org/petitions/gilead-sciences-please-collaborate-with-bristol-myers-for-the-cure-for-hepatitis-c-now For clinical trials, you could start here: http://www.clinicaltrials.
Avatar m tn How should I assure myself that drug I am taking is not duplicate and it is original and manufactured by Bristol-Myers Squibb.I am affraid of frauds and asking this question for my peace of my mind as we know this is expensive one. Please suggest me way to verify it.Please let me know if you require some information from myside. 2. Any idea when can I stop treatment? 3.My daughter and spouse vacinated in 2004 do they need buster dose now or after sometime ?
Avatar m tn Bristol Myers Squibb have a low income assistance program http://www.bms.com/products/patient-assistance/Pages/baraclude-uninsured.
Avatar f tn I have heard the goal is to be able to combine the new drugs Bristol-Myers is working on with the Interferon Lambda to create a cocktail that will reduce treatment time significantly along with making the treatment very tolerable. They are talking 24 weeks for G1 & 4 and 12 weeks for G2 & 3 with very few side effects. I have also heard they will be starting a study in the next few months with this new cocktail of drugs.
Avatar n tn The best thing to do is to contact Bristol Myers Squibb, the company that manufactures Baraclude, they have programs to provide Baraclude free or at low cost to those in need.
Avatar m tn //www.kens5.com/news/health/Hepatitis-C-patients-petitioning-for-life-saving-drug-combination-160728485.html www.change.org/petitions/gilead-sciences-please-collaborate-with-bristol-myers-for-the-cure-for-hepatitis-c-now This my fellow Heppers......is a start. I applaud mdudley and appreciate all of her efforts, and I am following in her foot steps. Please join us in continuing this fight and lets get that "Awareness" and the "CURE" More to come!
Avatar f tn One of the medicines he is currently on is Entecavir (Baraclude by Bristol Myers Squibb). My question is does anyone of a program in the Philippines that can help me and my family pay for it?
393432 tn?1212209678 s a tough situation. Depending on your financial situation, you may want to look into Bristol-Myers Squibb Company to see if they have a patients assistant program. Changing insurance is a possible consideration. Baraclude comes in 0.5mg and 1mg. If you have to go with Baraclude, check the cost for the 1mg compare with the 0.5mg. If they cost you about the same out of pocket, go with the 1mg, cut it in half and you get twice the dosage.
Avatar f tn call bristol-myers at 8882818981. explain to them your situation. they will probably have you fill an application . you will also need to fax them a copy of your most recent w2. i think they have a program where you can pay little money to even zero money.